Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Colin D. Weekes, M.d., Phd, explained in plain language.
This study tests whether adding two experimental drugs (elraglusib and losartan) to standard chemotherapy (FOLFIRINOX) can prevent metastatic pancreatic cancer from becoming resistant to treatment. About 70 adults with untreated, advanced pancreatic cancer will receive the combin…
Phase: PHASE2 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC